ElevateBio
ElevateBio develops genetic medicine technologies and manufacturing services for biopharma partners. The company has raised $1.2 billion, including a Series D in May 2023, and employs 450 people.
The growth story
ElevateBio grew from 260 to 450 employees between 2021 and 2026, raising $1.2B along the way, most recently a Series D in May 2023.
About
ElevateBio provides gene editing technologies and end-to-end manufacturing services for genetic medicines. Its ecosystem combines Life Edit, its gene editing R&D business, with BaseCamp, its process development and manufacturing arm, to accelerate therapeutic development.
The company has scaled rapidly since its 2017 founding, reaching 450 employees. Its $1.2 billion in funding, including a recent Series D, positions it as a major player in genetic medicine infrastructure.
Founders and leadership
Engineering is ElevateBio's largest function, accounting for 33% of analyzed profiles. The company operates with a relatively flat structure, with a median tenure of 2 years suggesting frequent turnover.
The ElevateBio org chart
Christopher Murphy (Chief Executive Officer) leads 59 mapped leaders with 7 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 77 (-25% YoY), Operations 66 (+10% YoY), Quality Assurance 65 (+8% YoY), Business Development 47 (+7% YoY), Information Technology 22 (0% YoY), Engineering 17 (-6% YoY).
Talent flow
ElevateBio recruits heavily from major pharma companies, with Sanofi (27 hires) and Thermo Fisher Scientific (24) being top sources. Northeastern University is the most common alma mater, accounting for 25 of analyzed profiles.
Most common previous employers of ElevateBio staff: Sanofi (27), Thermo Fisher Scientific (24), bluebird bio (18), Takeda (14), Biogen (10), Moderna (10). Former ElevateBio employees most often moved to Vertex Pharmaceuticals (10), Bristol Myers Squibb (9), Lonza (4), Editas Medicine (3), Bond Global (2), TPG (2).
Alumni worth knowing
The ElevateBio mafia
ElevateBio alumni have founded 9 companies, including EnPlusOne Biosciences (27 staff) and NueCell Bio (11 staff). These startups focus on biotech and related fields, continuing ElevateBio's scientific legacy.
9Clare Murray, was Head, Business Development and Strategy until 2025Michael Wourms, was Senior Director Manufacturing until 2020Matthew Therkelsen, was Associate Director, BaseCamp Business Development until 2024Dr Claire Bergstrom Johnson, was Associate Scientist II, Stem Cell Differentiation R&D until 2021Varun Sheel, was Senior Associate Scientist until 2023Kareem Reda, was Chief Business Officer until 2023
Mona Haratianfar, was Senior Associate Scientist, Cellular Process Development and Emerging Technologies until 2023
Joshua Farb Ph.D., was Director CMC / Process Development / R&D (circRNA / mRNA) until 2024
George O'Sullivan, was Head of Supply Chain until 2021Hiring now
Web traffic
Traffic mix: 48% direct, 35% search, 11% social, 1% paid.
What this company is made of
Most common skills at ElevateBio: Microsoft Office (141), Good Manufacturing Practice (GMP) (122), Leadership (109), Microsoft Excel (108), Cell Culture (107), Research Skills (91), Biotechnology (90), Data Analysis (88).
Where the team actually sits
ElevateBio people are concentrated in Massachusetts, United States (104), Greater Boston (63), North Carolina, United States (20), United States (18).
Search footprint
ElevateBio attracts about 1,166 organic search visits a month, traffic worth roughly $2K a month if bought through ads. It gained 106 ranking keywords and lost 85 in the last period.
What employees say
- Compensation
- 3.90 / 5
- Career opportunities
- 3.10 / 5
- Senior management
- 2.70 / 5
- Work-life balance
- 3.20 / 5
Frequently asked
ElevateBio has 450 employees as of September 2026.
ElevateBio has raised $1.2B in total, most recently a Series D round in May 2023.
Christopher Murphy (Chief Executive Officer) sits at the top of ElevateBio's reporting structure, with 7 direct reports.
The most common previous employers of current ElevateBio staff are Sanofi (27 people), Thermo Fisher Scientific (24 people), bluebird bio (18 people).
Former ElevateBio employees most often move to Vertex Pharmaceuticals (10), Bristol Myers Squibb (9), Lonza (4).
At least 9 companies have a founder who previously worked at ElevateBio, including EnPlusOne Biosciences, NueCell Bio, Taurus BioVentures.
ElevateBio attracts about 1,166 organic search visits a month, worth roughly $2K a month in equivalent ad spend.
The most common skills among ElevateBio staff are Microsoft Office, Good Manufacturing Practice (GMP), Leadership, Microsoft Excel, Cell Culture.
ElevateBio staff are concentrated in Massachusetts, United States (104), Greater Boston (63), North Carolina, United States (20).
ElevateBio has about 77 people in Research, down 25% over the past year, as of September 2026.
ElevateBio has about 66 people in Operations, up 10% over the past year, as of September 2026.
Computed from 247 current and 238 former ElevateBio profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.